证券日报网讯2月3日，芭田股份（002170）在互动平台回答投资者提问时表示，公司2025年11月10日股 东人数为72444户。 ...

近日，随着国内12家肥料上市企业陆续发布2025年业绩预告，过去一年行业不同板块表现差异明显：在 原材料价格剧烈波动、政策调控持续加码、下游需求结构性变化等多重因素交织影响下，氮肥企业受价 格低迷拖累，普遍承压运行；钾肥企业量价齐升、持续吸金；磷复肥企业则因资源禀赋、成本控制和产 品结构差异，业绩明显分化。 01 价格低迷，氮肥企业承压 2025年，氮肥市场持续低迷。据隆众资讯数据，山东地区尿素全年出厂均价为1694元/吨，较2024年下 跌352元/吨，价格波动区间明显收窄。在此背景下，以尿素为核心产品的氮肥企业普遍承压运行。 以尿素为重要盈利支柱之一的潞化科技（维权）预计，2025年归属上市公司股东净利润为-8.63亿~-6.38 亿元。公司坦言，2025年，尿素、聚氯乙烯等主产品价格长期低位运行，加之资产减值计提，进一步拖 累业绩。聚焦化工和医药大健康领域的赤天化预计，2025年归属上市公司股东净利润为-3.8亿~-2.88亿 元，其化工业务因停产大修导致产量下降、费用上升，煤炭板块亦受产量不足与售价下滑影响。 四川美丰预计，2025年实现归属上市公司股东净利润为-1.29亿~-0.98亿元。2025年 ...

内容概要：含腐植酸水溶肥料中的腐植酸是由天然有机物提取而来，是一种环保型的肥料。相比传统的 化肥，含腐植酸水溶肥料不会对土壤和环境造成过度的污染。同时，含腐植酸水溶肥料还能够改善土壤 结构，促进土壤中微生物的活性，增加土壤中的有机质含量，从而起到保护生态环境的作用。因此，含 腐殖酸水溶肥料是推动传统农业向高效生态农业转型的重要支撑。正是基于其突出的生态价值与农业应 用优势，含腐植酸水溶肥料的发展获得国家层面的高度重视。2025年中央一号文件首次明确将"氨基 酸、腐植酸等有机类水溶肥"列为国家农业绿色转型的核心支持范畴，并定位为"强化农业科技支撑"的 关键措施。这意味着含腐植酸水溶肥料从市场自发发展阶段正式进入了国家战略驱动的新阶段。在市场 需求和国家政策的作用下，我国含腐殖酸水溶肥料行业市场规模持续增长，2024年行业市场规模达到 430亿元，同比上涨17.3%。 相关上市企业：云天化（600096）、史丹利（002588）、芭田股份（002170）、红四方（603395）、苏 垦农发（601952）、北大荒（600598）、亚盛集团（600108）、新农开发（600359）、登海种业 （002041）等。 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002496 | *ST辉丰 | 1.88 | -5.05% | 38.17万 | | 7215.91万 | | 002513 | 蓝丰生化 | 7.18 | -3.23% | 15.85万 | | 1.15亿 | | 603360 | 百傲化学 | 33.23 | -2.49% | 18.48万 | | 6.15 亿 | | 002250 | 联化科技 | 17.72 | -2.10% | 37.28万 | | 6.60亿 | | 001231 | 农心科技 | 23.92 | -1.03% | 2.38万 | | 5736.71万 | | 300804 | 广康生化 | 36.75 | -0.68% | 8711.5 | | 3216.04万 | | 300387 | 富邦科技 | 9.29 | -0.54% | 7.62万 | | 7101.73万 | | 300261 | 雅本化学 | 7.52 | -0.53% | 29. ...

1月26日晚，先达股份发布2025年度业绩预告，预计全年实现净利润1.35亿元至1.55亿元，上年同期该指 标为亏损2587.55万元，实现同比扭亏为盈。 近期农化行业多家公司业绩大幅预喜。记者梳理发现，目前已有20家农化上市公司披露业绩预告，其中 10家业绩预增、2家扭亏。 多家农化上市公司业绩预增 对于业绩预增的原因，先达股份表示，核心系公司主要产品烯草酮销售价格较上年同期显著上涨，推动 公司产品毛利率整体提升；本年度创制产品吡唑喹草酯系列成功上市并实现销售，进一步带动国内制剂 产品毛利率增长。 与此同时，公司持续推进运营改革，实施毛利分配方案，强化成本费用管控，整体运行效率不断提高。 不止先达股份，农药化工板块多家企业均2025年业绩高增。草铵膦头部企业利尔化学于1月23日发布 2025年度业绩快报。报告期内，公司实现营业收入约90.08亿元，同比增加23.21%；归母净利润约4.79 亿元，同比增加122.33%。 对于这一成绩，利尔化学称，2025年行业虽然依旧面临激烈市场竞争，但公司凭借部分产品需求增长， 综合毛利率同比有所上涨以及降本增效取得成效，最终带动业绩同比上涨。 农药退税新政有望提振行业 ...

Investment Rating - The report maintains a strong rating for the chemical industry, indicating a positive outlook for the sector [5]. Core Insights - The chemical sector has shown resilience with the CITIC Basic Chemical Index rising by 5.73% and the Shenwan Chemical Index increasing by 7.29% this week [13][16]. - Key sub-industries such as soda ash, chlor-alkali, and dyeing chemicals have experienced significant price increases, with soda ash rising by 13.3% [16]. - The report highlights the competitive strength of domestic tire manufacturers and suggests focusing on companies like Sailun Tire and Linglong Tire as potential growth opportunities [4]. - The polyurethane project by Huide Technology, with an annual production capacity of 600,000 tons, has commenced, indicating strategic growth in the new materials sector [3]. - The report emphasizes the tightening supply-demand dynamics in the phosphate chemical sector due to environmental regulations and increasing demand from the new energy sector [4]. Summary by Sections Market Overview - The Shanghai Composite Index increased by 0.84%, while the ChiNext Index decreased by 0.34% [13]. - The overall performance of the chemical sector is positive, with notable gains in various sub-industries [16]. Key Sub-Industry Developments - **Polyurethane**: The price of pure MDI in East China is reported at 17,600 RMB/ton, showing a week-on-week decline of 1.12% [28]. - **Tires**: The operating load for all-steel tires in Shandong is at 62.70%, reflecting a year-on-year increase of 20.70% [49]. - **Fertilizers**: Urea prices are at 1,757.45 RMB/ton, with a week-on-week decrease of 0.4% [63]. - **Vitamins**: The price of Vitamin A is reported at 61.5 RMB/kg, down 1.6% week-on-week [79]. Investment Themes - **Tire Sector**: Domestic tire companies are positioned strongly, with a focus on growth stocks [4]. - **Consumer Electronics**: Recovery in demand is anticipated, benefiting upstream material companies [4]. - **Phosphate Chemicals**: Supply constraints due to environmental policies are expected to tighten the market [4]. - **Vitamin Supply**: Supply disruptions in Vitamin A and E are noted, creating potential investment opportunities [4].

Group 1 - Northeast Securities expects a net profit of 1.477 billion yuan in 2025, a year-on-year increase of 69.06% [1] - Gansu Energy anticipates a net profit of 1.95 billion to 2.1 billion yuan in 2025, representing a year-on-year growth of 18.6% to 27.72% [2] - Ningbo Bank reports a projected net profit of 29.333 billion yuan in 2025, with an 8.13% year-on-year increase [3] Group 2 - Qianyuan Power forecasts a net profit of 567 million to 633 million yuan in 2025, indicating a year-on-year growth of 160% to 190% [5] - Batian Co. expects a net profit of 890 million to 980 million yuan in 2025, reflecting a year-on-year increase of 117.53% to 139.53% [6] - Tongfu Microelectronics anticipates a net profit of 1.1 billion to 1.35 billion yuan in 2025, with a year-on-year growth of 62.34% to 99.24% [7] Group 3 - Zhongyuan Nepe expects a net profit of 368 million to 428 million yuan in 2025, representing a year-on-year increase of 80.47% to 109.9% [8] - Huajin Co. predicts a net loss of 1.6 billion to 1.9 billion yuan in 2025, compared to a loss of 2.795 billion yuan in the previous year [9] - Xinghua Co. anticipates a net loss of 420 million to 560 million yuan in 2025, up from a loss of 380 million yuan in the previous year [4] Group 4 - Huayuan Holdings expects a net profit of 107 million to 118 million yuan in 2025, a year-on-year increase of 50.98% to 66.82% [12] - Taishan Petroleum forecasts a net profit of 130 million to 165 million yuan in 2025, indicating a year-on-year growth of 30.88% to 66.11% [13] - Jiuqi Software anticipates a net profit of 40 million to 60 million yuan in 2025, recovering from a loss of 156 million yuan in the previous year [21] Group 5 - Jin Fang Energy expects a net profit of 109 million to 143 million yuan in 2025, reflecting a year-on-year increase of 123.97% to 193.7% [16] - He Sheng New Materials anticipates a net profit of 152 million to 171 million yuan in 2025, representing a year-on-year growth of 55% to 75% [24] - Yuedong Microelectronics predicts a net loss of 340 million to 425 million yuan in 2025 [14] Group 6 - Aibo Medical plans to acquire at least 51% of Demai Medical, with an estimated valuation of the target company not exceeding 1 billion yuan [26] - Zhaoshang Shipping intends to build four 3000TEU container ships with a total investment of no more than 1.324 billion yuan [18] - Zhongtung High-tech's subsidiary has confirmed an increase in mineral resources, adding significant quantities of tungsten and other metals [27]

芭田股份是一家以磷矿资源为基本盘、向下游功能肥与磷化工一体化延伸的企业。 近年来，随着公司旗下贵州小高寨磷矿进入稳定生产放量阶段，业绩迎来跃升：2025年前三季度实现归母净利润 6.87亿元，同比+236.13%。 【中信新材料】芭田股份：磷化工涨价核心受益，涨价增产业绩弹性+7%股息率 展望未来，伴随采选效率提升、扩产技改项目推进落地，在磷矿价格中枢稳中上移的背景下，公司盈利有望继续 保 矿端方面，公司现有安全许可产能为200万吨/年，290万吨/年扩建相关安全设施设计审查已于2025年11月获批 复。 产销量方面，公司每天产量在1.2万吨，折算年化实际产能远高于理论值；在此基础上，随着技改与二期扩产项目 推进、智能矿山持续投入，产量与效率仍有望提升。 价格方面，公司矿石以中高品位为主、售价随行就市；成本方面，根据公司公告，含税综合成本约400元/吨，在 磷矿价格维持高位的情况下，矿端利润确定性与弹性较强。 【中信新材料】芭田股份：磷化工涨价核心受益，涨价增产业绩弹性+7%股息率 芭田股份是一家以磷矿资源为基本盘、向下游功能肥与磷化工一体化延伸的企业。 近年来，随着公司旗下贵州小高寨磷矿进入稳定生产放量阶段 ...

【开源化工-日度数据跟踪＆反内卷产品跟踪】 各位领导，这是1月20日化工品价格价差及化工企业股价涨跌幅情况，1月20日： 上证综指报4113.65，日环比-0.01%；基础化工、石油化工分别报7785.68、4841.91，分别日环比+0.35%、 +2.58%。 反内卷产品中价格涨幅靠前的为：聚酯瓶片、己内酰胺，分别环比昨天+0.75%、0.54%。 价差涨幅前5为：磷酸铁锂、顺酐、硬泡聚醚、草甘膦、苯酚，分别环比昨天+52.62%、38.41%、37.5%、 29.24%、17.62%； 化工企业股价涨幅前5为：江天化学、怡达股份、润丰股份、七彩化学、红棉股份，分别环比昨天+19.99%、 11.96%、10.72%、10.71%、10.13%。 今日重点公告： 【东方铁塔】业绩预告：公司预计2025年归属于上市公司股东的净利润为10.8-12.7亿元，同比+91.4%-125.07%。 【芭田股份】业绩预告：公司预计2025年归属于上市公司股东的净利润为8.9-9.8亿元，同比+117.53%-139.53%。 价格涨幅前5为：R125、R22、烟酰胺、丙烯酸、醋酸正丙酯，分别环比昨天+3.09%、2. ...

Group 1: Delisting Risks - *ST Xin Yan: The Shenzhen Stock Exchange has approved the company's application to revoke the delisting risk warning due to restructuring [1] - *ST Zhong Zhuang (Rights Protection): The delisting risk warning has been revoked, but other risk warnings will continue, and the stock will be suspended for one day starting tomorrow [2] - ST Sai Wei: Expected to incur a loss of 720 million to 1.02 billion yuan in 2025, with a possibility of being subject to delisting risk warnings [3] Group 2: Earnings Forecasts - Hikvision: Expected net profit attributable to shareholders to grow by 18.46% year-on-year in 2025 [28] - Langzi Co.: Expected net profit to increase by 245.25% to 302.8% year-on-year in 2025 [4][30] - Zhaoyan New Drug: Expected net profit to increase by 214% to 371% year-on-year in 2025 [5][30] - Huachen Equipment: Expected net profit to increase by 193.64% to 242.04% year-on-year in 2025 [6][30] - Qianyuan Power: Expected net profit to increase by 160% to 190% year-on-year in 2025 [7][30] - Jin Fang Energy: Expected net profit to increase by 123.97% to 193.7% year-on-year in 2025 [8][31] - Zhongfu Industrial: Expected net profit to increase by 120.27% to 141.59% year-on-year in 2025 [9][32] - Batian Co.: Expected net profit to increase by 117.53% to 139.53% year-on-year in 2025 [10][32] - Zhongrong Electric: Expected net profit to increase by 104.89% to 131.10% year-on-year in 2025 [11][32] - Kaisheng New Materials: Expected net profit to increase by 96.47% to 150.06% year-on-year in 2025 [12][32] - Putailai: Expected net profit to increase by 93.18% to 101.58% year-on-year in 2025 [13][32] - Dongfang Iron Tower: Expected net profit to increase by 91.4% to 125.07% year-on-year in 2025 [14][32] - Pulaike: Expected net profit to increase by 89.64% to 110.11% year-on-year in 2025 [15][32] - Huabang Health: Expected profit of 660 million to 730 million yuan in 2025, turning from loss to profit [16][32] - Hongyuan Green Energy: Expected net profit of 180 million to 250 million yuan in 2025, turning from loss to profit [17][32] - Kangda New Materials: Expected profit of 125 million to 135 million yuan in 2025, turning from loss to profit [18][32] - Langxin Technology: Expected profit of 100 million to 150 million yuan in 2025, turning from loss to profit [19][32] - Hualv Biological: Expected profit of 100 million to 130 million yuan in 2025, turning from loss to profit [20][32] Group 3: Mergers and Acquisitions - Kangxin New Materials: Plans to acquire 51% of Yubang Semiconductor for 392 million yuan [21][32] - Aibo Medical: Plans to gain control of Demei Medical [22][32] Group 4: Share Buybacks and Reductions - Hengtong Co.: Plans to repurchase company shares worth 80 million to 100 million yuan [24][32] - Haier Smart Home: Plans to repurchase D shares up to 200,000 euros [29][32] - Blue Universe Co.: Shareholders plan to reduce their holdings by no more than 3.02% [29][32] - Hesheng Silicon Industry: Controlling shareholder plans to reduce holdings by no more than 3% [29][32] - Aolian Electronics (Rights Protection): Shareholder Liu Junsheng plans to reduce holdings by no more than 3% [29][32] - Bluefeng Biochemical: Hainan Wenqin plans to reduce holdings by no more than 3% [29][32] - Zhixin Precision: Shareholders plan to reduce holdings by no more than 3% [29][32] - Peking University Medical: Peking University Health plans to reduce holdings by no more than 3% [29][32] Group 5: Other Updates - Liou Co.: Self-inspection work has been completed, and the stock will resume trading on January 21 [29][32] - Yongxing Materials: The lithium mica green intelligent and efficient lithium extraction project has reached production capacity [29][32] - Debang Co.: Plans to voluntarily withdraw A shares from trading on the Shanghai Stock Exchange [29][32]